The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes

[1]  L. Funk,et al.  Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study , 2021, Journal of medical Internet research.

[2]  K. Boye,et al.  Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019 , 2021, Diabetes Therapy.

[3]  C. Meyerhoefer,et al.  Direct medical costs of obesity in the United States and the most populous states , 2021, Journal of managed care & specialty pharmacy.

[4]  S. Purkayastha,et al.  Obstructive Sleep Apnea in Obese Patients: a UK Population Analysis , 2021, Obesity Surgery.

[5]  K. Boye,et al.  Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity. , 2020, Journal of diabetes and its complications.

[6]  M. Banerjee,et al.  Central Obesity is Associated With Neuropathy in the Severely Obese. , 2020, Mayo Clinic proceedings.

[7]  Hyejung Jung,et al.  Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial , 2020, European heart journal.

[8]  Craig M. Hales,et al.  Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. , 2020, NCHS data brief.

[9]  K. Baumgartner,et al.  Cirrhosis: Diagnosis and Management. , 2019, American family physician.

[10]  S. Woolf,et al.  Life Expectancy and Mortality Rates in the United States, 1959-2017. , 2019, JAMA.

[11]  P. Lambiase,et al.  Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities , 2018, Arrhythmia & electrophysiology review.

[12]  Jeremy A Rassen,et al.  Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases , 2018, Clinical epidemiology.

[13]  Xinqun Hu,et al.  Relationship of Obesity to Adverse Events Among Patients With Mean 10‐Year History of Type 2 Diabetes Mellitus: Results of the ACCORD Study , 2018, Journal of the American Heart Association.

[14]  A. Iannelli,et al.  Nutritional issues in patients with obesity and cirrhosis , 2018, World journal of gastroenterology.

[15]  B. Neuschwander‐Tetri,et al.  Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis , 2018, Hepatology.

[16]  D. Lloyd‐Jones,et al.  Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity , 2018, JAMA cardiology.

[17]  Ping Zhang,et al.  Economic Costs of Diabetes in the U.S. in 2017 , 2018, Diabetes Care.

[18]  M. Amini,et al.  Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus , 2018, Acta Diabetologica.

[19]  Alyson K. Myers,et al.  Obstructive Sleep Apnea and Obesity: Implications for Public Health. , 2017, Sleep medicine and disorders : international journal.

[20]  G. Frühbeck,et al.  Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way , 2017, Obesity Facts.

[21]  Ralph A. DeFronzo,et al.  Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? , 2017, Diabetes Care.

[22]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[23]  Frank B Hu,et al.  Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. , 2016, Circulation research.

[24]  Kristy Iglay,et al.  Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus , 2016, Current medical research and opinion.

[25]  T. Maddox,et al.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. , 2015, World journal of diabetes.

[26]  W. McNicholas,et al.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. , 2015, Journal of thoracic disease.

[27]  J. Cleland,et al.  The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis , 2015, Annals of Internal Medicine.

[28]  Paramdeep S Baweja,et al.  Obesity: the 'huge' problem in cardiovascular diseases. , 2013, Missouri medicine.

[29]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[30]  C. Maric,et al.  Obesity, metabolic syndrome and diabetic nephropathy. , 2011, Contributions to nephrology.

[31]  Francisco Lopez-Jimenez,et al.  Interactions between obesity and obstructive sleep apnea: implications for treatment. , 2010, Chest.

[32]  利光 久美子.  非アルコール性脂肪性肝疾患(NAFLD,non-alcoholic fatty liver disease)と非アルコール性脂肪肝炎(NASH,non-alcoholic steatohepatitis)の栄養評価に関する研究 , 2010 .

[33]  S. Grundy,et al.  Obesity, metabolic syndrome, and cardiovascular disease. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[35]  T. Saibara,et al.  [Nonalcoholic steatohepatitis (NASH)]. , 2002, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.